[1]张亚奇,曹银科,田彦军,等.ω-3多不饱和脂肪酸对胃癌细胞抑制作用及防治研究[J].医学信息,2023,36(16):169-173.[doi:10.3969/j.issn.1006-1959.2023.16.035]
 ZHANG Ya-qi,CAO Yin-ke,TIAN Yan-jun,et al.Study on the Inhibitory Effect and Prevention of ω-3 Polyunsaturated Fatty Acids on Gastric Cancer Cells[J].Journal of Medical Information,2023,36(16):169-173.[doi:10.3969/j.issn.1006-1959.2023.16.035]
点击复制

ω-3多不饱和脂肪酸对胃癌细胞抑制作用及防治研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年16期
页码:
169-173
栏目:
综述
出版日期:
2023-08-15

文章信息/Info

Title:
Study on the Inhibitory Effect and Prevention of ω-3 Polyunsaturated Fatty Acids on Gastric Cancer Cells
文章编号:
1006-1959(2023)16-0169-05
作者:
张亚奇曹银科田彦军
(1.天水市中西医结合医院肿瘤科,甘肃 天水 741020;2.天水市中西医结合医院消化科,甘肃 天水 741020;3.兰州大学第一医院药剂科,甘肃 兰州 730000)
Author(s):
ZHANG Ya-qiCAO Yin-keTIAN Yan-junet al.
(1.Department of Oncology,Tianshui Combine Traditional Chinese and Western Medicine Hospital,Tianshui 741020,Gansu,China;2.Department of Gastroenterology,Tianshui Combine Traditional Chinese and Western Medicine Hospital,Tianshui 741020,Gansu,China;3.Department of Pharmacy,the First Hospital of Lanzhou University,Lanzhou 730000,Gansu,China)
关键词:
ω-3多不饱和脂肪酸胃癌抑制活性化疗DHAEPA
Keywords:
ω-3 polyunsaturated fatty acidsGastric cancerInhibitory activityChemotherapyDHAEPA
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2023.16.035
文献标志码:
A
摘要:
胃癌在全球最普遍被诊断的癌症中排名第4,而且在所有癌症中死亡率排名第2,被视为国际上最重要的健康危机之一。遗传、生活环境、饮食习惯等诸多因素都会导致胃癌的发生。ω-3多不饱和脂肪酸(ω-3PUFAs)具有多种生物活性功能,并且在癌症的防治方面发挥着重要作用。目前,ω-3PUFAs在防治胃癌中作用及应用是这方面研究的热点。本文综述了ω-3PUFAs抑制胃癌细胞的作用及其机理、ω-3PUFAs预防及治疗胃癌等方面的研究,以期为ω-3PUFAs治疗胃癌的进一步研究提供思路。
Abstract:
Gastric cancer is the fourth most commonly diagnosed cancer in the world and the second highest mortality rate among all cancers, regarded as an important international health crisis. Many factors such as genetics, living environment, and dietary habits can lead to the occurrence of gastric cancer. Omega-3 polyunsaturated fatty acids (ω-3PUFAs) possess a variety of active functions and play an important role in the prevention and treatment of cancers. Currently, the function and application of ω-3 PUFAs in gastric cancer are the focus in these studies. This article reviews the role and mechanism of ω-3PUFAs in inhibiting gastric cancer cells, the prevention and treatment of gastric cancer by ω-3PUFAs, in order to provide ideas for further research on the treatment of gastric cancer by ω-3PUFAs.

参考文献/References:

[1]Zhao AL,Hou C,Li YZ,et al.Preoperative low muscle mass and malnutrition affect the clinical prognosis oflocally advanced gastric cancer patients undergoing radical surgery[J].Front Oncol,2023,13:1156359.[2]Ferro A,Peleteiro B,Malvezzi M,et al.Worldwide trends in gastric cancer mortality(1980-2011), with predictions to 2015,and incidence by subtype[J].Eur J Canc,2014,50:1330-1344.[3]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China, 2015[J].Cancer J Clin,2016,66(2):115-132.[4]Subhash VV,Yeo MS,Tan WL,et al.Strategies and advancements in harnessing the immune system for gastric cancer immunotherapy[J].J Immunol Res,2015,308574.[5]Orditura M,Galizia G,Sforza V,et al.Treatment of gastric cancer[J].World J Gastroenterol,2014,20(7):1635-1649.[6]Tang Y,Soroush F,Tong Z,et al.Targeted multidrug delivery system to overcome chemoresistance in breast cancer[J].Int J Nanomed,2017,12:671-681.[7]D’Eliseo D,Velotti F.Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy[J].J Clin Med,2016,5(2):15.[8]冯晓玲,高鸿亮,张琪琪,等.ω-3多不饱和脂肪酸对炎症性肠病患者免疫细胞功能及炎性指标的影响[J].现代消化及介入诊疗,2022,27(2):205-209.[9]Das UN.Essential Fatty acids - a review[J].Curr Pharm Biotechnol,2006,7(6):467-482.[10]Vedtofte MS,Jakobsen MU,Lauritzen L,et al.The role of essential fatty acids in the control of coronary heart disease[J].Curr Opin Clin Nutr Metab Care,2012,15(6):592-596.[11]SanGiovanni JP,Chew EY.The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina[J].Prog Retin Eye Res,2005,24(1):87-138.[12]Salem NJ,Litman B,Kim HY,et al.Mechanisms of action of docosahexaenoic acid in the nervous system[J].Lipids,2001,36(9):945-959.[13]Zarate R,El Jaber-Vazdekis N,Tejera N,et al.Significance of longchain polyunsaturated fatty acids in human health[J].Clin Transl Med,2017,6(1):25.[14]Murphy RA,Mourtzakis M,Chu QS,et al.Supplementationwith fish oil increases first-line chemotherapy efficacy in patientswith advanced nonsmall cell lung cancer[J].Cancer,2011,117:3774-3780.[15]Garcia CP,Lamarque AL,Comba A,et al.Synergistic anti-tumor effects of melatoninand PUFAs from walnuts in a murine mammary adenocarcinomamodel[J].Nutrition(Burbank,Los Angeles County,Calif),2015,31(4):570-577.[16]Trombetta A,Maggiora M,Martinasso G,et al.Arachidonic and docosahexaenoic acids reduce thegrowth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs[J].Chem BiolInteract,2007,165(3):239-250.[17]Yang B,Ren XL,Fu YQ,et al.Ratio of n-3/n-6 PUFAs and risk of breast cancer:a meta-analysis of 274135 adult females from 11 independent prospective studies[J].BMC Cancer,2014,14:105.[18]Murff HJ,Shu XO,Li H,et al.A prospective study of dietary polyunsaturated fatty acids and colorectal cancer risk in Chinesewomen[J].Cancer Epidemiol Biomark Prevent,2009,18(8):2283-2291.[19]Ostermann AI,Waindok P,Schmidt MJ,et al.Modulation of the endogenous omega-3 fattyacid and oxylipin profile in vivo-A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet[J].PLoS One,2017,12:e0184470.[20]Siddiqui RA,Harvey KA,Xu Z,et al.Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects[J].Biofactors,2011,37:399-412.[21]Dai J,Shen J,Pan W,et al.Effects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro[J].Lipids Health Dis,2013,12:71.[22]Shakeri S,Amoozyan N,Fekrat F,et al.Antigastric Cancer Bioactive Aurantiochytrium Oil Rich in Docosahexaenoic Acid: From Media Optimization to Cancer Cells Cytotoxicity Assessment[J].J Food Sci,2017,82(11):2706-2718.[23]巩涛,李勇,郭建文,等.ω-3多不饱和脂肪酸对人胃癌BGC-823细胞周期及凋亡的影响[J].中国临床营养杂志, 2006,14(2):77-79.[24]Sheng H,Li P,Chen XH,et al.Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1[J].Front Biosci,2014,19:854-861.[25]Ortega L,Lobos-Gonzalez L,Reyna-Jeldes M,et al.The Ω-3 fatty acid docosahexaenoic acid selectively induces apoptosis in tumor-derived cells and suppress tumor growth in gastric cancer[J].Eur J Pharmacol,2021,896:173910.[26]Huang XC,Wang M,Wang HS,et al.Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid[J].Bioorg Med Chem Lett,2014,24(6):1511-1518.[27]Luo DJ,Ni Q,Ji A,et al.Dehydroabietic Acid Derivative QC4 Induces Gastric Cancer Cell Death via Oncosis and Apoptosis[J].Biomed Res Int,2016,2016:2581061.[28]史浩,马家驰,陈泉,等.多不饱和脂肪酸ω-3和ω-3对胃癌侵袭影响的研究[J].中华肿瘤防治杂志,2012,19(2):1700-1703.[29]Sheng H,Chen X,Liu B,et al.Omega-3 polyunsaturated fatty acids enhance cisplatin efficacy in gastric cancer cells by inducing apoptosis via ADORA1[J].Anticancer Agents Med Chem,2016,16:1085-1092.[30]Gao K,Liang Q,Zhao ZH,et al.Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells[J].World J Gastroenterol,2016,22(10):2971-2980.[31]Shekari N,Javadian M,Ghaffari S,et al.DHA Abolishes the Detrimental Effect of Docetaxel on Downregulation of the MICA via Decreasing the Expression Level of MicroRNA-20a in Gastric Cancer[J].J Gastrointest Cancer,2019,51(2):545-551.[32]Shekari N,Javadian M,Ghasemi M,et al.Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer[J].J Gastrointest Cancer,2020,51(1):70-75.[33]Karla SL,Jenny GT,Eva JH,et al.Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer:Randomised trial[J].Clin Nutr,2014,33(6):1017-1023.[34]Mao JT,Xue B,Fan S,et al.Leucoselect Phytosome Modulates Serum Eicosapentaenoic Acid, Docosahexaenoic Acid, and Prostaglandin E3 in a Phase I Lung Cancer Chemoprevention Study[J].Cancer Prev Res,2021,14(6):619-626.[35]Camacho-Mu?觡oz D,Niven J,Kucuk S,et al.Omega-3 polyunsaturated fatty acids reverse the impact of western diets on regulatory T cell responses through averting ceramide-mediated pathways[J].Biochem Pharmacol,2022,204:115211.[36]Merino J,Sala-Vila JA,Kones R,et al.Increasing long-chain n-3PUFA consumption improves small peripheral artery function in patients at intermediate-high cardiovascularrisk[J].J Nutr Biochem,2014,25(6):642-646.[37]Lee S,Lee J,Choi J,et al.Dietary n-3 and n-6 polyunsaturated fatty acids,the FADS gene,and the risk of gastric cancer in a Korean population[J].Sci Rep,2018,8:3823.[38]Ko KJ,Shim JH,Yoo HM,et al.The clinical value of non-curative resection followed by chemotherapy for incurable gastric cancer[J].World J Surg,2012,36(8):1800-1805.[39]王海云,武进华,王凯.围术期护理干预对肱骨近端骨折患者心理状态及应激因子的影响[J].中国医药导报,2017,14,31:169-172.[40]Pratt VC,Watanabe S,Bruera E,et al.Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation[J].Br J Cancer,2002,87(12):1370-1378.[41]刘玉猛,张新胜,刘钊,等.含ω-3多不饱和脂肪酸的肠内营养对胃癌患者营养状况及生活质量的影响[J].中华临床营养杂志,2020,28(3):151-157.[42]崔亚平,赵锐,王勇,等.早期含ω-3多不饱和脂肪酸肠内营养联合静脉补充丙氨酰谷氨酰胺对胃癌根治术后患者炎症反应及免疫功能的作用[J].中国普外基础与临床杂志,2019,26(7):785-790.[43]Ma CJ,Wu JM,Tsai HL,et al.Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients[J].Nutr J,2015,14:9.[44]Eltweri AM,Thomas AL,Fisk HL,et al.Plasma and erythrocyte uptake of omega-3 fatty acids from an intravenous fish oil based lipid emulsion in patients with advanced oesophagogastric cancer[J].Clin Nutr,2017,36(3):768-774.[45]梁涛,伍晓汀.ω-3多不饱和脂肪酸对老年胃癌患者术后谵妄的预防作用[J].中国普外基础与临床杂志,2019,26(2):174-179.

相似文献/References:

[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
 YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(16):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
 RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Journal of Medical Information,2018,31(16):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
 DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Journal of Medical Information,2018,31(16):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
 PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Journal of Medical Information,2018,31(16):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
 LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Journal of Medical Information,2022,35(16):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[6]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
 LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(16):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[7]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
 LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Journal of Medical Information,2018,31(16):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[8]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
 MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Journal of Medical Information,2018,31(16):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[9]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
 ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Journal of Medical Information,2018,31(16):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[10]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
 WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(16):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]

更新日期/Last Update: 1900-01-01